Incidental renal cell carcinoma


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

P. A Tyan

V. V Dutov

References

  1. Ferlay J., Autier P, Boniol M. et al. Estimates of the cancer incidens and mortality in Europe in 2006. Ann Oncol. 2007;18:581-592.
  2. Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg. 2004;93(2):88-96.
  3. Чиссов В.И., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2007 году. М. ФГУ «МНИОИ им. П.А. Герцена росмедтехнологий». 2009. 244 с.
  4. Аполихин О.И., Сивков А.В., Солнцева Т.В. и др. Анализ урологической заболеваемости в Российской Федерации в 2005-2010 годах. Экспериментальная и клиническая урология. 2012;2:4-12.
  5. Ficarra V., Martignoni G., Lohse C. et al. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer - specific survival using a European series of conventional renal cell carcinoma. J. Urol. 2006; 175(4): 1235-1239.
  6. Chow W.H., McLaughin J.K., Mandel J.S. et al. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs and hypertension. Cancer Epidemiol. Biomarkers Prev. 1995;4:327-331.
  7. Jacqmin D., van Poppel H„ Kirkali Z., Mickisch G. Renal cancer. Eur. Urol. 2001;39:361-369.
  8. Parsons J.K., Jarrett T.J., Chow G.K. et al. The effect of intraabdominal adhesions at laparoscopy for urological tumors. J. Urol. 2002;168(6):2387-2390.
  9. Аляев Ю.Г., Крапивин A.A. Резекция почки при раке. М.: Медицина. 2001. 198 с.
  10. Ries L.A., Eisner M.P., Kosary C.L. et al. SEER Cancer Statistics Review. National Cancer Institute. 2003:1975-2002.
  11. Аляев Ю.Т., Крапивин A.A. Локализованный и местнораспространенный рак почки: нефрэктомия или резекция? Онкоурология. 2005;1:10-15.
  12. Pantuck A.J., Zisman A., Rauch M.K. et al. Incidental renal tumors. Urology. 2000;56:190-196.
  13. Kytikov A. Forrest L.k, Ramchandani P. et al. Incidence of beging pathologic findings at partial nefrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperated imaiging. Urology. 2006;68(4):737-740.
  14. Гусев А.А. Клинико-морфологические особенности инцидентального почечно-клеточного рака. Автореф. дисс. канд. мед. наук. М., 2007.
  15. Rubagotti A., Martorana G, Boccardo F. Epidemiology of kidney cancer. EAU. 2006;5(Suppl.):558-565.
  16. Amling C.L. The associadon between obesity and the progression of prostate and renal cell carcinoma. Urol. Oncol. 2004;22:478-484.
  17. Hu J., Мао Y., White K. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Cancer Causes Control. 2003;14(8):705 -714.
  18. Buzio L., Tondel M., De Palma G. et al. Occupational risk factors for renal cell cancer. An Italian case-control study. Med. Lav. 2002;93:303-309.
  19. Adami J., Gabel H., Lindelof B. et al. Cancer risk follow in organ transplantadon: a nationwide cohort study in Sweden. Br. J. Cancer. 2003;89:1221-1227.
  20. Linehan W.M., Zbar B. Focus on kidney cancer. Cancer Cell. 2004;6:223-228.
  21. Wagner B. et al. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur. Urol. 2009;55:452-459.
  22. Tsui K.H., Shvarts O., Smith R.B. et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol. 2000; 163(4):1090-1095.
  23. Slow W.Y., Yip S.K.H., Ng L.G. et al: Renal cell carcinoma: incidental detection and pathological staging. J.R. Coll. Surg. Edinb. 2000;45(5):291.
  24. Gudbjartsson T. Hardarson S., Petusdottir V. et al. Histological subtyping and nuclear grading of renal cell carcinoma and implications for survival: a retrospective nation-wide study of 629 patients. Eur. Urol. 2005;48:593.
  25. Lang H. et al. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: assessment of 241 patients with > 15-year follow-up. Cancer. 2005;103(3):625-629.
  26. Bretheau D., Lechevallier E., De Fromont M. et al. Prognostic value of nuclear grade of renal cell carcinoma. Cancer. 1995;76:2543-2549.
  27. Grossman E., Messerli F.H., Boyko V. et al. Is there an association between hypertension and cancer mortality? Am. J. Med. 2002;112:479-486.
  28. Bos S.D., Mellema C.T., Mensink H.J. Increase in incidental renal cell carcinoma in the northern part of the Netherlands. Eur. Urol. 2000;37:267.
  29. Papworth K., Grankvist K., Ljungberg B. et al. Parathyroid Hormone-Related Protein and Serum Calcium in Patients with Renal Cell Carcinoma. Tumour. Biol. 2005;26:201-206.
  30. Носов А.К. Клинические проявления, диагностика и стадирование рака паренхимы почки. Практическая онкология. 2005;6(3):148-155.
  31. Li G., Feng G. Gentil-Perret A. et al. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol. 2008;180(2):510-513.
  32. Sabatino M., Kim-Shulze S., Paneli M.C. et al. Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy. J Clin. Oncol. 2009;27(16):2645-2652.
  33. Zegeuner R., Hutterer G., Chromecki T. et al. External validation of the Mayo Clinic stage, size, grade and necrosis (SSING) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Eur. Urol. 2010;57:102-109.
  34. Isbarn H., Karakiewicz P.I. Predicting cancer-control outcomes in patients with renal cell carcinoma. Curr. Opin. Urol. 2009; 19:247-257.
  35. Аляев Ю.Г., Григорян З.Г., Левко А.А. Опухоль почки в сочетании с поражением противоположной неонкологическим заболеванием. Онкоурология. 2008;1:8-15.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies